Blueprint Medicines Corp (BPMC) stock is lower by -27.54% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives BPMC stock a score of 24 out of a possible 100. That rank is chiefly influenced by a short-term technical score of 4. BPMC's rank also includes a long-term technical score of 18. The fundamental score for BPMC is 50. In addition to the average rating from Wall Street analysts, BPMC stock has a mean target price of $113.33. This means analysts expect the stock to add 52.82% over the next 12 months.
BPMC has an Overall Score of 24. Find out what this means to you and get the rest of the rankings on BPMC!